Treating multiple myeloma with high-level dose chemotherapy supported by transplanted autologous stem cells is still the primary and appropriate therapeutic strategy in affected patients. Today, although the responses have improved considerably, especially during the treatment with the induction of the combination of immunomodulatory medication and proteasome blockers, no treatment approach has taken autologous stem cell transplantation into the background. In this review, we will share the recent place of autologous stem cell transplantation in myeloma will be discussed from pretransplant treatment to posttransplant.
Autologous stem cell transplantation indication multiple myeloma.
Autologous stem cell transplantation indication multiple myeloma.
Birincil Dil | İngilizce |
---|---|
Konular | Sağlık Kurumları Yönetimi |
Bölüm | Review Articles |
Yazarlar | |
Erken Görünüm Tarihi | 6 Ekim 2023 |
Yayımlanma Tarihi | 30 Eylül 2023 |
Gönderilme Tarihi | 11 Şubat 2023 |
Kabul Tarihi | 21 Mart 2023 |
Yayımlandığı Sayı | Yıl 2023 Cilt: 40 Sayı: 3 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.